alpha-En Corp - FORM 10-K - XML - IDEA: XBRL DOCUMENT - April 16, 2012



Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR16.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR5.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR14.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR13.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR15.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR11.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR12.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR4.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR1.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR17.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR3.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR7.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR6.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR2.htm
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR8.htm
EXCEL - IDEA: XBRL DOCUMENT - alpha-En CorpFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - alpha-En CorpR9.htm
EX-32.1 - EXHIBIT 32.1 - alpha-En Corpv309128_ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - alpha-En Corpv309128_ex31-1.htm
EX-21.1 - EXHIBIT 21.1 - alpha-En Corpv309128_ex21-1.htm
10-K - 10-K - alpha-En Corpv309128_10k.htm
v2.4.0.6
Intangible Assets
12 Months Ended
Dec. 31, 2011
Intangible Assets
4. Intangible Assets

 

On February 25, 2009, the Company was granted an exclusive, worldwide, transferable, perpetual license (License) to use certain proprietary technology for the processing of lithium for use in batteries and other fields. A patent application relating to the licensed technology is pending.

In exchange for the License, the Company:

 

(1) issued 1,000,000 shares of common stock of the Company;

 

(2) issued an additional 2,000,000 shares of common stock of the Company which are restricted and subject to forfeiture if there has not been at least $1,000,000 in total commercial sales of licenses products within three years (Threshold);

 

(3) will pay royalties of $1.00 per kilogram, of lithium products manufactured and sold, payable quarterly;

 

(4) will pay a royalty of $.01 per kilogram, of excess products manufactured and sold, payable quarterly;

 

(5) will grant options to purchase up to a total of 19% (inclusive of previously issued shares) of the issued and outstanding shares of the Company upon the issuance of any additional shares after the date of the License. These options are exercisable at the same prices as the shares sold or values received for five years from each grant date. These grants are only issuable if the Threshold is met.

 

Upon a transfer of the entire License, the Company shall pay the licensor a fee equal to 19% of all compensation received on the transfer.

 

The License has been recorded at its fair value of $250,000 based on management’s projected net cash flows to be realized from sales of products under the License.

 

Pursuant to the terms of the License Agreement, the additional 2,000,000 shares of the Company’s common stock, which were issued, are subject to forfeiture if there has not been at least $1,000,000 in total commercial sales of licenses products by February 25, 2012.

 

As of February 25, 2012, commercial sales of the licensed products have not commenced.

 

As of December 31, 2011, the Company has evaluated the fair value of the Technology License intangible asset and has determined that it is in excess of the carrying value based on our estimated net discounted cash flows anticipated from the sale of the process under the licensing agreement. The Company has also continued to test the process and believes that it is workable and commercially feasible.

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by alpha-En Corp and has no official or unofficial affiliation with alpha-En Corp


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.